Mutations in the XPC Gene in Families with Xeroderma Pigmentosum and Consequences at the Cell, Protein, and Transcript Levels1
Total Page:16
File Type:pdf, Size:1020Kb
[CANCER RESEARCH 60, 1974–1982, April 1, 2000] Mutations in the XPC Gene in Families with Xeroderma Pigmentosum and Consequences at the Cell, Protein, and Transcript Levels1 Franz Chavanne, Bernard C. Broughton, Daniela Pietra, Tiziana Nardo, Alison Browitt, Alan R. Lehmann, and Miria Stefanini2 Istituto di Genetica Biochimica ed Evoluzionistica CNR, 27100 Pavia, Italy [F. C., D. P., T. N., M. S.], and MRC Cell Mutation Unit, Sussex University, Falmer, Brighton BN1 9RR, United Kingdom [B. C. B., A. B., A. R. L.] ABSTRACT (3). The patients from this group usually show only skin disorders and no neurological abnormalities. Cultured fibroblasts from XP-C pa- Xeroderma pigmentosum (XP)-C is one of the more common comple- tients exhibit very limited UV-induced DNA repair synthesis levels, mentation groups of XP, but causative mutations have thus far been ranging between 10 and 20% of normal, and are specifically defective reported for only six cases (S. G. Khan et al., J. Investig. Dermatol., 115: 791–796, 1998; L. Li et al., Nat. Genet., 5: 413–417, 1993). We have now in GGR. They are, however, capable of removing damage from the extended this analysis by investigating the genomic and coding sequence of transcribed strand of active genes at normal rates (4–6). the XPC gene, the level of expression of the XPC transcript and the status Phenotypic correction of XP-C cells by cDNA transfection resulted of the XPC protein in 12 unrelated patients, including all of the 8 Italian in the cloning of a partial but fully active XPC cDNA (7). The XP-C cases identified thus far and in 13 of their parents. Eighteen full-length cDNA, isolated by Masutani et al. (8), is 3558 nts long and mutations were detected in the open reading frame of the XPC gene, 13 of the encoded 940-amino-acid product shows limited homology with which are relevant for the pathological phenotype. The mutations are the Rad4 protein of Saccharomyces cerevisiae. The human XPC gene distributed across the gene, with no indication of any hotspots or founder spans about 24 kb, the transcribed sequence being divided into 15 effects. Only 1 of the 13 relevant changes is a missense mutation, the exons (9). remainder causing protein truncations as a result of nonsense mutations Masutani et al. (8) showed that the XPC gene encodes a M 125,000 (3), frameshifts (6), deletion (1) or splicing abnormalities (2). These find- r ings indicate that the XPC gene is not essential for cell proliferation and protein that is present in a tight complex with the Mr 58,000 protein viability and that mutations causing minor structural alterations may not encoded by hHR23B, one of the two human homologues of the yeast give an XP phenotype and may not, therefore, be identified clinically. RAD23 gene. Almost all of the XPC molecules appear to be com- XP13PV was the only patient carrying a missense mutation (Trp690Ser on plexed in vivo with hHR23B. Recent studies have shown that XPC- the paternal allele). This was also the only patient in which the XPC hHR23B binds to a variety of NER lesions and carries out the first transcript was present at a normal level and the XPC protein was detect- step in NER (damage recognition) in transcriptionally inactive DNA able, although at a lower than normal level. No quantitative alterations in (10, 11). the transcript or protein levels were detected in the XP-C heterozygous Characterization of the molecular defects in XP-C patients may parents. However, the expression of the normal allele predominated in all provide a tool to define further the biological role of the XPC protein, of them, except the father of XP13PV, which suggests the existence of a as well as the sites relevant for its activity. Thus far, six XP-C cell possible mechanism for monitoring the amount of the XPC protein. lines have been characterized at the cDNA level, and eight mutations including point mutations, deletions and insertions have been de- INTRODUCTION scribed (12, 13). In this report, we describe the clinical features and the cellular 3 NER is the principal pathway for removal of a broad spectrum of phenotype of 12 XP-C patients (8 from Italy, 1 from the United structurally unrelated lesions such as UV-induced cyclobutane pyrim- Kingdom, and 3 of Middle Eastern origin), as well as the mutations idine dimers and 6–4 photoproducts, and numerous chemical adducts. detected in the genomic and coding sequence of the XPC gene. For the The NER system has two distinct subpathways: (a) TCR, which Italian patients, the molecular analysis was extended to the parents to rapidly removes lesions from the transcribed strand of active genes; determine the allele inheritance and the linkage relationship of muta- and (b) GGR, which effects the slower repair of the rest of the genome tions. We have also investigated the level of expression of the XPC (recently reviewed in Ref. 1). Defects in NER have been found in transcript by Northern analysis and the occurrence of the XPC protein association with three rare human autosomal recessive syndromes, by Western analysis. which include XP. XP is clinically characterized by extreme sensitiv- ity to sun-exposure, sunlight-induced pigmentation abnormalities, and MATERIALS AND METHODS a high incidence of skin cancer (2). Progressive neurological degen- eration is found in a proportion of patients. Case Reports. The study was performed on 12 patients showing clinical Complementation tests by cell fusion have provided evidence for symptoms typical of XP and classified by genetic analysis into the XP-C the existence of at least seven NER-deficient complementation group. The 8 patients coded with the suffix PV represent all of the XP-C cases groups: XP-A to XP-G. XP group C is one of the more common forms identified in Italy thus far. XP4BR is a typical XP-C patient of Middle Eastern origin (14). XP4RO is of historical interest as it was the first XP to be used in complementation analysis (15). XP6BR is a very unusual patient, who, at the Received 9/23/99; accepted 2/2/00. The costs of publication of this article were defrayed in part by the payment of page age of 67, had had multiple self-healing melanomas (16). XP14BR was charges. This article must therefore be hereby marked advertisement in accordance with unusual in that, apart from the expected sensitivity to UV light, both the 18 U.S.C. Section 1734 solely to indicate this fact. individual and her cells were sensitive to ionizing radiation. Clinical features 1 Supported by Associazione Italiana Ricerca sul Cancro Grant (to M. S.), by EC and related literature references for all of the patients are reported in Table 1. Human Capital and Mobility Grant CHRX-CT94-0443 (to M. S. and A. R. L.), and by EC contract QLG1-1999-00181. In common with most XP-C individuals described in the literature, none of the 2 To whom requests for reprints should be addressed, at Istituto di Genetica Biochimica analyzed cases showed neurological abnormalities. ed Evoluzionistica CNR, via Abbiategrasso 207, 27100 Pavia, Italy. Phone: 39-0382- Cells and Culture Conditions. Primary fibroblast cultures were estab- 546330; Fax: 39-0382-422286; E-mail: [email protected]. lished from biopsies of unaffected skin obtained from the 12 patients and 11 3 The abbreviations used are: NER, nucleotide excision repair; TCR, transcription- coupled repair; GGR, global genome repair; XP, xeroderma pigmentosum; UDS, unsched- parents. Fibroblasts were routinely grown in Ham’s F-10 medium (Life Tech- uled DNA synthesis; nt, nucleotide. nologies, Inc., Rockville, MD) supplemented with 12% FCS (Irvine, Santa 1974 Downloaded from cancerres.aacrjournals.org on September 26, 2021. © 2000 American Association for Cancer Research. GENOTYPE-PHENOTYPE RELATIONSHIPS IN XP-C Table 1 Clinical features and DNA repair data of the 12 XP-C patients analyzed in this study Ocular Age at last Skin Age at Repair synthesis Patient Sex examination (yr) tumors onset (yr) Lesions Tumors (% of normal) Reference XP5PV M 21 ϩ 12 ϩϪc 15 This article XP9PVa M35 ϩ 15 ϩϩ 15 37 XP10PV F 15b ϩ 4 ϩϩ 20 This article XP12PV M 5 ϪϪϪ20 This article XP13PV M 14 ϩ 4 ϩϪ 20 This article XP18PVa F9 ϩ 8 ϪϪ 18 This article XP19PV M 4 ϪϩϪ20 This article XP26PV M 3 ϪϪϪ10 This article XP4RO F 16 ϩ 10 15 XP4BR M 13 ϩ 20 14 XP6BR M 67 ϩ 28 10 16 XP14BR F 19b ϩ 11 Ϫ 10 38 a Parents are consanguineous. b Age at death. c Ϫ, symptoms not present. Ana, CA) or Eagle’s MEM (Life Technologies, Inc.) supplemented with 15% Northern Blot Analysis. RNA was extracted by a cesium chloride-gradi- FCS (PAA Laboratories, Teddington, United Kingdom). Fibroblasts from eight ent centrifugation procedure from samples of 2 ϫ 107 fibroblasts or 1 ϫ 108 healthy donors (C1PV, C3PV, B119, CF, FB345, FB377, FB380, FB383) and lymphoblastoid cells resuspended in 1 ml of guanidinium thiocyanate buffer [4 from two XP patients previously assigned to group C were used as reference M guanidinium thiocyanate and 3 M sodium acetate (pH 6)]. strains in the study. Total RNA (5 g) was electrophoresed on 1.2% agarose formaldehyde gel, Lymphoblastoid cell lines were established by EBV transformation of stained with ethidium bromide, and blotted onto Hybond-N membrane (Am- peripheral blood lymphocytes from a normal donor (352/96), XP26PV, and the ersham). Hybridization was carried out by overnight incubation with an XPC parents of the latter. These cell lines were cultured in RPMI 1640 (Sigma, St. probe corresponding to cDNA nts 286-1413.